Regulation

Senate Report Highlights Deteriorating Care in Private Equity-Owned Hospitals
Care Senate Report Highlights Deteriorating Care in Private Equity-Owned Hospitals

A recent investigation led by the U.S. Senate Committee on the Budget has raised alarm over the deteriorating care in hospitals owned by private equity (PE) firms across the United States. This bipartisan probe, spearheaded by Senators Chuck Grassley and Sheldon Whitehouse, delved into the growing

Turkey Health Workers Protest Against Profit-Driven Regulations
Public Policy Turkey Health Workers Protest Against Profit-Driven Regulations

Health workers in Turkey’s primary health system have launched a five-day protest against new regulations that prioritize commercialization and profit over patient care. Beginning on January 6, the protests have included rallies across Turkey and culminated in a nationwide healthcare strike to e

Can New FDA Guidelines Reduce Racial Bias in Pulse Oximeters?
Technology Can New FDA Guidelines Reduce Racial Bias in Pulse Oximeters?

The U.S. Food and Drug Administration (FDA) has recently issued new guidelines to tackle the issue of racial bias in devices that measure oxygen levels in the blood, known as pulse oximeters. These guidelines arose from the importance of this issue during the COVID-19 pandemic, when inaccuracies in

How Should AI-Enabled Medical Devices Be Monitored Postmarket?
Technology How Should AI-Enabled Medical Devices Be Monitored Postmarket?

In a groundbreaking move to ensure patient safety and device efficacy, the FDA has recently issued comprehensive guidance on the lifecycle management of AI-enabled medical devices, emphasizing the importance of proactive monitoring and long-term performance management. This directive addresses the

Are Pulse Oximeters Accurate Across Different Skin Tones?
Data and Information Are Pulse Oximeters Accurate Across Different Skin Tones?

The accuracy of pulse oximeters, devices commonly used to estimate blood oxygen levels, has come under scrutiny due to evidence suggesting performance discrepancies across different skin tones. This issue has prompted the US Food and Drug Administration (FDA) to propose new draft guidance aimed at

Hospital M&A in 2024: Stability on the Surface, Distress Underneath
Business Hospital M&A in 2024: Stability on the Surface, Distress Underneath

The year 2024 has been a paradoxical one for the hospital and health system sector. On the surface, the industry appears to be stabilizing, with improved operating margins and positive outlooks from key rating agencies. However, a deeper analysis reveals ongoing financial distress and significant

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later